What's the Prognosis? Making infusion systems safer.
نویسنده
چکیده
Two years ago, more than 300 people gathered outside Washington, D.C. to tackle one of the most pressing challenges in healthcare— making infusion devices and systems safer. What’s changed? The AAMI/FDA Infusion Device Summit in October of 2010 has proven to be a catalyst for healthcare professionals who care about one of the most important safety issues of our time— infusing patients safely. Two years out, the ripple effects from the summit and the events that prompted it are only increasing in magnitude and impact. Today, more people are talking, working together, and committing to making the system of delivering intravenous (IV) therapy safer. What’s different now? Here’s a look at some of the progress to date:
منابع مشابه
What's happening in postgraduate medical education?
"It is a secret, both in nature and state, that it is safer to change many things at once." (Francis Bacon, "Of Regiment of Health", Essays, 1625).
متن کاملDecentralized prognosis of fuzzy discrete-event systems
This paper gives a decentralized approach to the problem of failure prognosis in the framework of fuzzy discrete event systems (FDES). A notion of co-predictability is formalized for decentralized prognosis of FDESs, where several local agents with fuzzy observability rather than crisp observability are used in the prognosis task. An FDES is said to be co-predictable if each faulty event can be...
متن کاملContinuous Infusion of Vancomycin in non-ICU Patients: Why, How and What's the Benefit?
197 words (max. 250)
متن کاملFalse Dawns and New Horizons in Patient Safety Research and Practice
In response to a weight of evidence that patients are frequently harmed as a result of their care, there have been concerted efforts to make healthcare safer, with health systems across the globe investing significant resources in policies and programmes designed to reduce adverse events. Yet, despite extensive efforts, improvements in safety have proved difficult to sustain and spread, with st...
متن کاملInhaled treprostinil and pulmonary arterial hypertension
Multiple conditions result in development of pulmonary hypertension. Pulmonary arterial hypertension (PAH) is the subclassification of pulmonary hypertension, in which known or unknown underlying conditions lead to similar intrinsic alterations in the pulmonary vasculature. PAH is a progressive condition characterized by restricted blood flow through the pulmonary circulation leading to poor su...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Biomedical instrumentation & technology
دوره 46 5 شماره
صفحات -
تاریخ انتشار 2012